These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23289518)

  • 21. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
    Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
    Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin.
    Ruivard M; Lainé F; Ganz T; Olbina G; Westerman M; Nemeth E; Rambeau M; Mazur A; Gerbaud L; Tournilhac V; Abergel A; Philippe P; Deugnier Y; Coudray C
    J Hepatol; 2009 Jun; 50(6):1219-25. PubMed ID: 19398238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress of the study on iron disorder diseases].
    Wang L; Duan XL; Wang YZ; Chang YZ; Qian ZM
    Sheng Li Ke Xue Jin Zhan; 2007 Oct; 38(4):307-12. PubMed ID: 18232299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does obesity increase risk for iron deficiency? A review of the literature and the potential mechanisms.
    Cepeda-Lopez AC; Aeberli I; Zimmermann MB
    Int J Vitam Nutr Res; 2010 Oct; 80(4-5):263-70. PubMed ID: 21462109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
    Détivaud L; Island ML; Jouanolle AM; Ropert M; Bardou-Jacquet E; Le Lan C; Mosser A; Leroyer P; Deugnier Y; David V; Brissot P; Loréal O
    Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron-deficiency anemia secondary to mutations in genes controlling hepcidin.
    Cau M; Melis MA; Congiu R; Galanello R
    Expert Rev Hematol; 2010 Apr; 3(2):205-16. PubMed ID: 21083463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
    Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of higher iron in diet on iron levels and hepcidin mRNA expression levels in rats].
    Han W; Wang C; Su C; Xu X
    Wei Sheng Yan Jiu; 2008 Jul; 37(4):474-6. PubMed ID: 18839536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia.
    Lasocki S; Millot S; Andrieu V; Lettéron P; Pilard N; Muzeau F; Thibaudeau O; Montravers P; Beaumont C
    Crit Care Med; 2008 Aug; 36(8):2388-94. PubMed ID: 18664788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated systemic hepcidin and iron depletion in obese premenopausal females.
    Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Guzman G; Holterman AX; Braunschweig C
    Obesity (Silver Spring); 2010 Jul; 18(7):1449-56. PubMed ID: 19816411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
    Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
    Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of hepcidin in obese patients: impact on phenotypic expression of hemochromatosis and pathophysiology of dysmetabolic iron overload syndrome.
    Lainé F; Deugnier Y
    Gastroenterology; 2006 Dec; 131(6):2028. PubMed ID: 17188970
    [No Abstract]   [Full Text] [Related]  

  • 33. Iron and steatohepatitis.
    Corradini E; Pietrangelo A
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():42-6. PubMed ID: 22320915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
    Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron metabolism: iron deficiency and iron overload.
    Andrews NC
    Annu Rev Genomics Hum Genet; 2000; 1():75-98. PubMed ID: 11701625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of hepcidin in iron homeostasis and anemia in hemodialysis patients.
    Eleftheriadis T; Liakopoulos V; Antoniadi G; Kartsios C; Stefanidis I
    Semin Dial; 2009; 22(1):70-7. PubMed ID: 19250447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors accounting for high ferritin levels in obesity.
    Lecube A; Hernández C; Pelegrí D; Simó R
    Int J Obes (Lond); 2008 Nov; 32(11):1665-9. PubMed ID: 18779821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepcidin--the discovery of a small protein with a pivotal role in iron homeostasis].
    Sela BA
    Harefuah; 2008 Mar; 147(3):261-6, 276. PubMed ID: 18488871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive changes of duodenal iron transport proteins in celiac disease.
    Barisani D; Parafioriti A; Bardella MT; Zoller H; Conte D; Armiraglio E; Trovato C; Koch RO; Weiss G
    Physiol Genomics; 2004 May; 17(3):316-25. PubMed ID: 15054143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron homeostasis: transport, metabolism, and regulation.
    Guo S; Frazer DM; Anderson GJ
    Curr Opin Clin Nutr Metab Care; 2016 Jul; 19(4):276-81. PubMed ID: 27137899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.